TOTAL VOLUME:

$154.3b

24H VOL:

$228,458,490

24H TRANSACTIONS:

2,984,028,936

OPEN INTEREST:

$1,879,276,037

410,833

Markets across

40,345

events

MATCHED EVENTS:

4,363

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Insights
Indices
API
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Elections
Crypto
Companies
Financials
Economics
Other
Entertainment
Science and Technology
Sangal vs. 100 Thieves
kalshi

Sangal vs. 100 Thieves

Volume:
$78,640

100 Thieves

 - Kalshi

100 Thieves - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Oct 16, 2026

Closed: Oct 16, 3:19 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

100 Thieves

View
100%
Yes 100¢No 0¢
—
N/A
$54,881
N/A
N/A
$41,110
Settled
Yes
kalshi

Sangal

View
0%
Yes 0¢No 100¢
—
N/A
$23,759
N/A
N/A
$15,799
Settled
No
Total markets: 2

Description

This market centers on the outcome of a professional Counter-Strike 2 match between two teams, Sangal and 100 Thieves, scheduled for October 16, 2026. The result depends solely on which team secures a victory in the match. If the match does not start within 48 hours of its scheduled time, or is canceled or forfeited before play begins, the market resolves based on fair pricing principles.

Kalshi

The market resolves based on the result of the Stake Pulse Beat III 2026: Sangal vs. 100 Thieves CS2 match scheduled for October 16, 2026, at 1:00 PM EDT. If the match is postponed and does not commence within 48 hours of its original scheduled start time, is canceled before any play begins, or is forfeited prior to the start of play, the market resolves to the fair market price. If the match begins and is later forfeited, the market resolves according to the official result declared by the governing body or tournament organizer. The market specifically tracks the full match result, with no partial or in-progress outcomes considered.